Early, consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent joint damage. An international review led by Josef S. Smolen of the Medical University of Vienna ...
Sep 11, 2026
0
9
Why do genetic variants that increase the risk of autoimmune disease remain so common in the population?
Sep 11, 2026
0
8
Axial spondyloarthritis (axSpA) is an inflammatory condition that causes chronic back pain and, if left untreated, can lead to fusion of the spinal or sacroiliac joints. The condition frequently remains underdiagnosed, with ...
Sep 10, 2026
0
6
In an Arthritis & Rheumatology analysis of data on 60,980 U.S. adults with autoimmune rheumatic conditions who developed COVID-19 between December 2020 and August 2024, those who received booster or updated (2023–2024) COVID-19 ...
Sep 9, 2026
0
7
Patients with rheumatic conditions and opioid use disorder (OUD) have distinct demographic and clinical characteristics, including lower use of disease-modifying antirheumatic drugs (DMARDs) and higher acute care use, according ...
Sep 8, 2026
0
3
Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in JCI Insight.
Sep 8, 2026
0
12
A shared biological mechanism that helps explain chronic exhaustion in conditions including long COVID and PTSD has been identified by researchers at the University of East Anglia and Oxford BioDynamics. The paper, published ...
Sep 2, 2026
3
581
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
Sep 1, 2026
0
4
Why do some joints remain chronically inflamed in osteoarthritis and other rheumatic diseases? Researchers have taken an important step toward answering this question. Their findings, published in the journal Cell Death & ...
Aug 31, 2026
0
784
When the immune system encounters a virus, it produces antibodies designed to recognize and eliminate the invader. But in some people infected with SARS-CoV-2, the virus that causes COVID-19, the immune response goes awry, ...
Aug 28, 2026
0
98
